LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells
Open Access
- 13 August 2010
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 425
Abstract
As EBV-associated gastric cancer has unique features that are different from EBV (-) gastric cancer, EBV is considered to have a key role in gastric carcinogenesis. It has been reported that viral latent membrane protein 2A (LMP2A) in EBV-transformed tumor cells activates the phosphatidylinositol 3-kinase (PI3K)/AKT pathway, which provides a survival signal and chemo-resistance to cytotoxic anti-cancer drugs. This study was to evaluate anti-proliferative effect and cell cycle change when 5-FU and LY294002 (LY), a selective inhibitor of PI3K, were treated separately or combined with different schedules in EBV positive gastric cancer cell line, SNU-719.Keywords
This publication has 33 references indexed in Scilit:
- Epstein‐Barr virus and gastric carcinomaPathology International, 2010
- Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer CellsCancer Research, 2008
- Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinomaCancer Science, 2006
- Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancerInternational Journal of Cancer, 2005
- Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2AJournal of Virology, 2005
- Current status and future prospects of chemotherapy for metastatic gastric cancer: a reviewGastric Cancer, 2005
- Epstein–Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathwayOncogene, 2004
- Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphomaBlood, 2003
- Virally targeted therapies for EBV-associated malignanciesOncogene, 2003
- Infrequent Overexpression of p53 Protein in Epstein‐Barr Virus‐associated Gastric CarcinomasJapanese Journal of Cancer Research, 1997